Difference between revisions of "Adenocarcinoma of the urinary bladder"
Jump to navigation
Jump to search
(→IHC: +sign out sample) |
|||
| Line 55: | Line 55: | ||
*[[Urachal carcinoma]] - dome of bladder. | *[[Urachal carcinoma]] - dome of bladder. | ||
*Invasive [[urothelial carcinoma]] with glandular differentiation - has urothelial differentiation. | *Invasive [[urothelial carcinoma]] with glandular differentiation - has urothelial differentiation. | ||
*[[Metastatic]] adenocarcinoma | *[[Metastatic]] adenocarcinoma ''or'' extension of [[adenocarcinoma]] from a nearby structure | ||
**[[Colorectal adenocarcinoma]]. | **[[Colorectal adenocarcinoma]]. | ||
**[[Prostatic adenocarcinoma]] - esp. [[ductal adenocarcinoma of the prostate]]. | |||
**[[Endometrioid endometrial adenocarcinoma]]. | |||
===Images=== | ===Images=== | ||
Revision as of 21:28, 30 April 2015
| Adenocarcinoma of the urinary bladder | |
|---|---|
| Diagnosis in short | |
 Adenocarcinoma of the urinary bladder. H&E stain. | |
|
| |
| Synonyms | primary adenocarcinoma of the urinary bladder |
|
| |
| LM | nuclear pleomorphism (may be mild), usually glandular differentiation (most common), no urothelial differentiation - essential |
| LM DDx | urachal carcinoma, invasive urothelial carcinoma with glandular differentiation, metastatic adenocarcinoma (esp. colorectal adenocarcinoma) |
| IHC | CK7 +ve, CK20 +ve, CDX2 +ve (strong, diffuse), beta-catenin +ve (membranous, not nuclear) |
| Grossing notes | radical cystectomy grossing, cystoprostatectomy grossing |
| Site | urinary bladder |
|
| |
| Prevalence | rare |
| Treatment | cystectomy |
Adenocarcinoma of the urinary bladder, also primary adenocarcinoma of the urinary bladder and bladder adenocarcinoma, is a very uncommon malignant urinary bladder tumour.
General
Clinical:
- Like urothelial carcinoma - usually hematuria.[1]
Microscopic
Features:
- Nuclear pleomorphism - may be mild.
- Usually glandular differentiation (most common).
- Frequently looks just like colorectal adenocarcinoma.
- Without urothelial differentiation - essential.[3]
Subtypes:[2]
- Glandular.
- Papillary.
- Colloidal (mucinous).
- Signet ring cell carcinoma.
- Clear cell carcinoma (also mesonephroid carcinoma).
DDx:
- Urachal carcinoma - dome of bladder.
- Invasive urothelial carcinoma with glandular differentiation - has urothelial differentiation.
- Metastatic adenocarcinoma or extension of adenocarcinoma from a nearby structure
Images
Case 1
AUB - low mag. (WC)
AUB - intermed. mag. (WC)
AUB - high mag. (WC)
IHC
Features - variable:[4]
- CK7 +ve.
- CK20 +ve.
- CDX2 +ve (strong, diffuse).
- Beta-catenin +ve (membranous, not nuclear).
- Colorectal adenocarcinoma typically has nuclear staining and membranous staining.
- Thrombomodulin +ve/-ve (~60% of cases).
- Colorectal adenocarcinoma -ve.
- Urothelial carcinoma +ve (~90% of cases).
Images
Case 1
AUB - beta-catenin - low mag. (WC)
AUB - beta-catenin - intermed. mag. (WC)
AUB - beta-catenin - high mag. (WC)
AUB - beta-catenin - very high mag. (WC)
Sign out
Urinary Bladder Tumour, Transurethral Resection: - Invasive adenocarcinoma into the lamina propria, see comment. - Muscularis propria not sampled. - Negative for lymphovascular invasion. Comment: No urothelial carcinoma component is identified. The differential diagnosis includes (1) primary adenocarcinoma of the bladder, (2) adenocarcinoma from another organ (direct extension or metastasis), (3) urothelial carcinoma with glandular differentiation without sampled urothelial carcinoma, and (4) urachal adenocarcinoma. Immunostaining of the tumour is as follows: POSITIVE: CK7, CK20, CK34betaE12. NEGATIVE: beta-catenin (membranous pattern only, nuclei are negative). The immunoprofile (beta-catenin = nuclei negative, CK7 = positive) and presence of an in situ component favours a primary adenocarcinoma of the bladder; however, this is uncommon. Nonprimary adenocarcinoma (e.g. colorectal adenocarcinoma) should be excluded clinically.
See also
References
- ↑ 1.0 1.1 Ranadive, NU.; Trivedi, VD.; Gadgil, NM. (Oct 1999). "Primary adenocarcinoma of the urinary bladder: a study of 6 cases from the pathologist's point of view.". Arch Esp Urol 52 (8): 906-11. PMID 11762445.
- ↑ 2.0 2.1 Abbas, M.; Kramer, MW.; Wolters, M.; Herrman, TR.; Becker, JU.; Kreipe, HH. (Feb 2013). "Adenocarcinoma of the urinary bladder, mesonephroid type: a rare case.". Rare Tumors 5 (1): e3. doi:10.4081/rt.2013.e3. PMID 23772302.
- ↑ Zhong, M.; Gersbach, E.; Rohan, SM.; Yang, XJ. (Mar 2013). "Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance.". Arch Pathol Lab Med 137 (3): 371-81. doi:10.5858/arpa.2012-0076-RA. PMID 23451748.
- ↑ Roy, S.; Parwani, AV. (Dec 2011). "Adenocarcinoma of the urinary bladder.". Arch Pathol Lab Med 135 (12): 1601-5. doi:10.5858/arpa.2009-0713-RS. PMID 22129192.